JP2010510994A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510994A5
JP2010510994A5 JP2009538564A JP2009538564A JP2010510994A5 JP 2010510994 A5 JP2010510994 A5 JP 2010510994A5 JP 2009538564 A JP2009538564 A JP 2009538564A JP 2009538564 A JP2009538564 A JP 2009538564A JP 2010510994 A5 JP2010510994 A5 JP 2010510994A5
Authority
JP
Japan
Prior art keywords
peptide
seq
immunogenic composition
composition
based immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009538564A
Other languages
English (en)
Japanese (ja)
Other versions
JP5177451B2 (ja
JP2010510994A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2007/002164 external-priority patent/WO2008064488A1/en
Publication of JP2010510994A publication Critical patent/JP2010510994A/ja
Publication of JP2010510994A5 publication Critical patent/JP2010510994A5/ja
Application granted granted Critical
Publication of JP5177451B2 publication Critical patent/JP5177451B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009538564A 2006-11-30 2007-11-30 インフルエンザワクチン製剤 Expired - Fee Related JP5177451B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86800806P 2006-11-30 2006-11-30
US60/868,008 2006-11-30
PCT/CA2007/002164 WO2008064488A1 (en) 2006-11-30 2007-11-30 Influenza vaccine formulation

Publications (3)

Publication Number Publication Date
JP2010510994A JP2010510994A (ja) 2010-04-08
JP2010510994A5 true JP2010510994A5 (OSRAM) 2011-01-27
JP5177451B2 JP5177451B2 (ja) 2013-04-03

Family

ID=39467397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009538564A Expired - Fee Related JP5177451B2 (ja) 2006-11-30 2007-11-30 インフルエンザワクチン製剤

Country Status (6)

Country Link
US (2) US7807173B2 (OSRAM)
EP (1) EP2097103B1 (OSRAM)
JP (1) JP5177451B2 (OSRAM)
CN (1) CN101622009B (OSRAM)
CA (1) CA2670965C (OSRAM)
WO (1) WO2008064488A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101622009B (zh) * 2006-11-30 2012-08-22 变异生物技术公司 流感疫苗制剂
AU2009259964B2 (en) 2008-06-19 2015-04-09 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
WO2011138032A2 (en) * 2010-05-05 2011-11-10 Artemev, Timur Universal influenza vaccines and methods for their generation
US20140328876A1 (en) 2011-11-18 2014-11-06 Variation Biotechnologies Inc. Synthetic derivatives of mpl and uses thereof
WO2017031353A1 (en) 2015-08-19 2017-02-23 Rutgers, The State University Of New Jersey Novel methods of generating antibodies
WO2018054840A1 (en) 2016-09-20 2018-03-29 Boehringer Ingelheim Vetmedica Gmbh New promoters

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118874B2 (en) * 1998-10-09 2006-10-10 Variation Biotechnologies Inc. Immunogenic formulation and process for preparation thereof
US6896881B1 (en) * 1999-09-24 2005-05-24 Mayo Foundation For Medical Education And Research Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
CN1163271C (zh) * 2000-08-10 2004-08-25 清华大学 一种合成肽流感疫苗的制备方法
AP2393A (en) * 2002-02-08 2012-04-04 Variation Biotechnologies Inc Immunogenic formulations of variable peptidic epitopes and process for preparation thereof.
AU2004220549B2 (en) * 2003-03-07 2007-07-05 Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Influenza virus vaccine
JP4939531B2 (ja) * 2005-06-01 2012-05-30 ヴァリエーション バイオテクノロジーズ インコーポレイテッド ペプチドベースのインフルエンザワクチン製剤
EP1948227A4 (en) * 2005-10-26 2010-03-31 Protelix Inc COMBINATORY ANTIGEN VACCINE AGAINST FLU
JP2009514536A (ja) 2005-11-07 2009-04-09 シドニー キンメル キャンサー センター Cd40リガンド融合蛋白質ワクチン
US20100074916A1 (en) * 2006-10-10 2010-03-25 Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And Avian influenza vaccine
CN101622009B (zh) * 2006-11-30 2012-08-22 变异生物技术公司 流感疫苗制剂

Similar Documents

Publication Publication Date Title
JP2010534684A5 (OSRAM)
JP2006006329A5 (OSRAM)
JP2009524695A5 (OSRAM)
JP2006213929A5 (OSRAM)
JP2010065037A5 (OSRAM)
IL247741B (en) Pharmaceutical preparations containing iron oxo-hydroxide, methods for their preparation and their uses
JP2011526809A5 (OSRAM)
JP2013510581A5 (OSRAM)
JP2009533064A5 (OSRAM)
JP2010088434A5 (OSRAM)
JP2009504138A5 (OSRAM)
JP2010510994A5 (OSRAM)
JP2007510403A5 (OSRAM)
IL209304A0 (en) Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
JP2009520682A5 (OSRAM)
JP2006305390A5 (OSRAM)
JP2008533990A5 (OSRAM)
JP2008519810A5 (OSRAM)
JP2012501302A5 (OSRAM)
JP2009507121A5 (OSRAM)
JP2008545704A5 (OSRAM)
贺裴 Study Finds Shark Overfishing May Lower Scallop Population
KIT et al. Make up
怀宝峰 et al. 吉林省杜荒岭金矿床地质特征及成矿规律浅析
Ara ঢোঁড়াই চরিতমানস'-এ নিম্নবর্গের জীবন